Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

KYTHERA BIOPHARMACEUTICALS INC (KYTH)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-15Mar-31-15Dec-31-14Sep-30-14Jun-30-14Mar-31-14Dec-31-13Sep-30-13
   10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q
Net income  -112.7-95.0-135.6-125.4-114.5-107.2-51.9-55.9
Depreciation and amortization   [+]0.60.40.30.20.10.10.20.4
Stock-based compensation  17.614.012.410.99.78.56.55.2
Change in working capital   [+]52.050.348.740.534.637.237.728.1
Other operating activities  -34.9-36.114.719.420.216.9-37.3-27.6
Cash from operations  -77.3-66.4-59.5-54.4-49.8-44.5-44.9-49.8
   
Capital expenditures  -1.9-2.3-2.1-1.9-0.8-0.10.0-0.1
Purchases of short-term investments, net  -43.111.1-16.2-50.2-20.1-27.0-56.5 
Other cash from investing  -0.5       
Cash from investing  -45.48.9-18.3-52.1-20.9-27.1-56.5-29.5
   
Issuance of common stock, net  0.0135.0    125.0 
Option exercises  1.31.1 1.30.52.3  
Other cash from financing  132.7-3.7-3.2-2.7-2.70.49.8 
Cash from financing  131.4130.2-4.5121.0121.7123.2133.689.4
   
Free cash flow  -79.2-68.7-61.6-56.3-50.6-44.6-44.9-49.9
        Per share (diluted)  ($3.36)($3.02)($2.75)($2.61)($2.46)($2.28)($2.41)($3.31)
   
Cash paid for interest  2.3 1.21.31.1 1.6 

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy